Randomized comparison of EZetimibe-FENOfibrate combination therapy added to moderate-intensity statins versus double-dose statin therapy in very high-risk patients with elevated remnant cholesterol (EZ-FENO Trial)

Authors
Category Primary study
Registry of TrialsKorean Clinical Trials Database
Year 2025
This article has no abstract
Epistemonikos ID: d6beeb0f373c3de07aa1385fb935a855d1184bb2
First added on: Apr 22, 2026